Barclays’s Silver Standard Resources SSRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-124,900
Closed -$1.21M 7356
2017
Q2
$1.21M Buy
124,900
+76,500
+158% +$768K ﹤0.01% 2706
2017
Q1
$514K Sell
48,400
-2,100
-4% -$22.2K ﹤0.01% 3380
2016
Q4
$450K Buy
50,500
+3,500
+7% +$35.4K ﹤0.01% 3465
2016
Q3
$567K Sell
47,000
-4,900
-9% -$66.1K ﹤0.01% 3117
2016
Q2
$674K Buy
51,900
+20,700
+66% +$192K ﹤0.01% 2949
2016
Q1
$156K Sell
31,200
-14,900
-32% -$78.7K ﹤0.01% 4030
2015
Q4
$231K Buy
46,100
+19,600
+74% +$118K ﹤0.01% 3796
2015
Q3
$159K Buy
26,500
+3,900
+17% +$23.7K ﹤0.01% 4300
2015
Q2
$136K Buy
22,600
+12,900
+133% +$76.2K ﹤0.01% 4434
2015
Q1
$39K Sell
9,700
-17,600
-64% -$97.8K ﹤0.01% 5454
2014
Q4
$137K Buy
27,300
+2,700
+11% +$14.2K ﹤0.01% 4940
2014
Q3
$147K Sell
24,600
-12,600
-34% -$108K ﹤0.01% 5018
2014
Q2
$297K Sell
37,200
-31,400
-46% -$271K ﹤0.01% 4445
2014
Q1
$618K Buy
68,600
+38,800
+130% +$364K ﹤0.01% 3737
2013
Q4
$178K Sell
29,800
-10,200
-26% -$61.7K ﹤0.01% 5129
2013
Q3
$240K Sell
40,000
-19,000
-32% -$142K ﹤0.01% 4863
2013
Q2
$374K Buy
+59,000
New +$435K ﹤0.01% 4552

Other funds holding SSRI

Barclays's SSRI Position: Q3 2017 in Review

Barclays sold out of Silver Standard Resources (SSRI) in Q3 2017, closing a stake of 13,982 shares — an estimated $136K sold.

Barclays first reported a position in SSRI in Q2 2013 and held it in 17 quarters. The position peaked at $402K in Q2 2013. 1 fund tracked by Wall St. Rank holds SSRI as of Q3 2017.

  • Barclays reported no remaining Silver Standard Resources position as of Q3 2017 after selling out during the quarter.
  • Barclays sold 13,982 Silver Standard Resources shares in Q3 2017, an estimated $136K.
  • Barclays first reported a position in Silver Standard Resources in Q2 2013 and held it in 17 quarters.
  • Barclays's Silver Standard Resources position peaked at $402K in Q2 2013.
  • 1 fund tracked by Wall St. Rank held Silver Standard Resources as of Q3 2017.

Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.